NATtrol SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL)

NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab gene region. NATtrol™ SARS-CoV2 (E/ORF1ab recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.

PRODUCT DESCRIPTION:
NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock* is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 sequence. The cells have been chemically modified to render them noninfectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock in a purified protein matrix.

PRODUCT DESCRIPTION:
NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock* is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 sequence. The cells have been chemically modified to render them noninfectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock in a purified protein matrix.

PRECAUTIONS:
• Although NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock contains inactivated bacteria, it should be handled as if potentially infectious.
• Use Universal Precautions when handling this product.
• To avoid cross-contamination, use separate pipette tips for all reagents.

RECOMMENDED STORAGE:
• NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock should be stored at 2-8°C.

INSTRUCTIONS FOR USE:
• Extract nucleic acid prior to use in downstream assays.

Concentration
(Ct Range)** 22-25

**Cycle threshold (Ct) range based on in-house real time PCR
assay targeting the SARS-CoV-2 ORF1ab gene.

DO NOT USE IN HUMANS. FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
These products are intended for research, product development, quality assurance or manufacturing use.
These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.